Evidence map›Paper›PMID 37242464›Full record

ReviewPharmaceuticals (Basel, Switzerland)2023

Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain.

Andrew Auyeung, Hank C Wang, Kannan Aravagiri, Nebojsa Nick Knezevic

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Andrew AuyeungAdvocate Illinois Masonic Medical Center, Department of Anesthesiology, Chicago, IL 60657, USA.
Hank C WangAdvocate Illinois Masonic Medical Center, Department of Anesthesiology, Chicago, IL 60657, USA.
Kannan AravagiriAdvocate Illinois Masonic Medical Center, Department of Anesthesiology, Chicago, IL 60657, USA.
Nebojsa Nick KnezevicAdvocate Illinois Masonic Medical Center, Department of Anesthesiology, Chicago, IL 60657, USA.ORCID 0000-0001-8028-1495
Advocate Illinois Masonic Medical Center · USRosalind Franklin University of Medicine and Science · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic pain is a pressing medical and socioeconomic issue worldwide. It is debilitating for individual patients and places a major burden on society in the forms of direct medical costs and lost work productivity. Various biochemical pathways have been explored to explain the pathophysiology of chronic pain in order to identify biomarkers that can potentially serve as both evaluators of and guides for therapeutic effectiveness. The kynurenine pathway has recently been a source of interest due to its suspected role in the development and sustainment of chronic pain conditions. The kynurenine pathway is the primary pathway responsible for the metabolization of tryptophan and generates nicotinamide adenine dinucleotide (NAD

Indexed as

biomarkerschronic paininflammationkynurenic acidkynurenine pathwayneurotoxicityquinolinic acidtryptophan metabolism

Identifiers

PMID37242464
PMCPMC10224279
OpenAlexW4368404642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.